ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 316

Effect of Vitamin D on Effusion-Synovitis in Knee Osteoarthritis:  a Randomized Controlled Trial

Xia Wang1, Flavia Cicutinni2, Xingzhong Jin1, Benny Samuel Eathakkattu Antony3, Anita Wluka2,4,5, Weiyu Han1, Leigh Blizzard6, Tania Winzenberg7, Graeme Jones8 and Changhai Ding8, 1Menzies institute for medical research, University of Tasmania, Hobart, Australia, 2Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, 3Musculoskeletal, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia, 4Epidemiology & Preventive Med, Monash University, Melbourne, Australia, 5Department of Epidemiology and Preventive Medicine, Monash University, Armadale, Australia, 6Statistics, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, 7Menzies Institute for Medical Research, University of Tasmania, Hobart,7000, Australia, 8Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Inflammation, osteoarthritis and synovial fluid, Vitamin D

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Osteoarthritis - Clinical Aspects Poster I: Treatments and Metabolic Risk Factors

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To examine the effect of vitamin D supplementation on synovial inflammation in patients with knee osteoarthritis (OA) and low vitamin D levels over 24 months. 

Methods: In a multi-center, parallel, randomized, placebo-controlled and double-blind trial, symptomatic knee OA patients with a low 25-(OH)D level (12.5 to 60 nmol/l) were recruited. 413 patients (age 63.2±7.0 years, 208 females) were allocated monthly to a 50,000IU vitamin D3 capsule (n=209) or placebo (n=204) for 24 months. In this post-hoc analysis, the primary outcome was change in total knee effusion-synovitis volume assessed using magnetic resonance imaging (MRI). Secondary outcomes included change in regional effusion-synovitis volume, change in semi-quantitative effusion-synovitis score and dichotomized minimal clinical important improvement in effusion-synovitis volume. Generalized linear regression models were used to compare differences between groups in both intention-to-treat and per protocol analyzes.

Results: Serum 25-(OH)D level increased markedly in the vitamin D group (40.6 nmol/l) compared with placebo (6.7 nmol/l) over 24 months. Overall total effusion-synovitis volume significantly increased in all patients (baseline: 8.0 ± 8.5 ml, follow-up: 9.0 ± 10.5 ml), but the increase was less in the vitamin D group than controls (0.26 ml (16% p.a.) versus 2.20 ml (60% p.a.), p = 0.02). This effect was evident in suprapatellar pouch (0.04 ml (19% p.a.) versus 2.53 ml (148% p.a.), p = 0.03), but not in central region (0.12 ml (10% p.a.) versus 0.40 ml (39% p.a.), p = 0.12). The likelihood of achieving a minimal clinical important improvement in total (relative risk: 1.22 p.a.; p = 0.05) and suprapatellar (relative risk: 1.27 p.a.; p = 0.03) effusion-synovitis were significantly higher in vitamin D group compared to placebo. Additionally, change in 25-(OH)D levels was negatively associated with change in total effusion-synovitis volume in whole sample (p = 0.09). Adverse events were similar.

Conclusion: Supplementation of vitamin D in knee OA patients over 24 months can reduce the worsening of knee joint effusion-synovitis, especially in suprapatellar pouch.


Disclosure: X. Wang, None; F. Cicutinni, None; X. Jin, None; B. S. Eathakkattu Antony, None; A. Wluka, None; W. Han, None; L. Blizzard, None; T. Winzenberg, None; G. Jones, None; C. Ding, None.

To cite this abstract in AMA style:

Wang X, Cicutinni F, Jin X, Eathakkattu Antony BS, Wluka A, Han W, Blizzard L, Winzenberg T, Jones G, Ding C. Effect of Vitamin D on Effusion-Synovitis in Knee Osteoarthritis:  a Randomized Controlled Trial [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/effect-of-vitamin-d-on-effusion-synovitis-in-knee-osteoarthritis-a-randomized-controlled-trial/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-vitamin-d-on-effusion-synovitis-in-knee-osteoarthritis-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology